These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
408 related articles for article (PubMed ID: 11654269)
1. The case of two devices: disclosure to subjects following Phase IV ("post-marketing") research. Anderson JR; Jameton A; Reitemeier PJ; Prentice E IRB; 1995; 17(3):6-9. PubMed ID: 11654269 [No Abstract] [Full Text] [Related]
2. Informed consent in the clinical research setting: experimentation on human subjects. Owens JF Med Trial Tech Q; 1987; 33(3):335-50. PubMed ID: 11653829 [No Abstract] [Full Text] [Related]
3. Informed consent in human experimentation: bridging the gap between ethical thought and current practice. Delgado R; Leskovac H UCLA Law Rev; 1986 Oct; 34(1):67-130. PubMed ID: 11659049 [No Abstract] [Full Text] [Related]
4. The regulation of human experimentation in the United States--a personal odyssey. Katz J IRB; 1987; 9(1):1-6. PubMed ID: 11649890 [No Abstract] [Full Text] [Related]
5. All is not well in research on human subjects. Goldman J N Y Times Web; 1986 Mar; ():A26. PubMed ID: 11647822 [No Abstract] [Full Text] [Related]
6. Balancing moral principles in federal regulations on human research. Ackerman TF IRB; 1992; 14(1):1-6. PubMed ID: 11652041 [No Abstract] [Full Text] [Related]
8. IRBs and pharmaceutical company funding of research. Jellinek MS; Levine RJ IRB; 1982 Oct; 4(8):9-10. PubMed ID: 11651693 [No Abstract] [Full Text] [Related]
9. The concept of the IRB and bureaucratic reality: an exchange of letters. van Eys J; Levine RJ IRB; 1984; 6(4):8-10. PubMed ID: 11649563 [No Abstract] [Full Text] [Related]
10. Institutional review boards in the university setting: review of pharmaceutical testing protocols, informed consent and ethical concerns. Kobasic DM J Coll Univ Law; 1988; 15(2):185-216. PubMed ID: 11659168 [No Abstract] [Full Text] [Related]
11. Faith (healing), hope and charity at the FDA: the politics of AIDS drug trials. Annas GJ Villanova Law Rev; 1989 Sep; 34(5):771-97. PubMed ID: 11651162 [No Abstract] [Full Text] [Related]
12. The changing clinical trials scene: the role of the IRB. Mitchell SC; Steingrub J IRB; 1988; 10(4):1-5. PubMed ID: 11650078 [No Abstract] [Full Text] [Related]
13. Considering experimentation and elusive truth: informed consent made difficult. Brodeur D Issues (St Louis Mo); 1992; 7(2):1-8. PubMed ID: 11659444 [No Abstract] [Full Text] [Related]
14. Informed consent: the FDA's perspective. Bagley G Food Drug Law J; 1993; 48(2):181-6. PubMed ID: 11653141 [No Abstract] [Full Text] [Related]
15. Protection of human subjects. United States Code Fed Regul Shipping; 1982 Oct; Part 46, Sections 46.101 to 46.306():. PubMed ID: 11660819 [No Abstract] [Full Text] [Related]
16. Protecting research subjects after consent: the case for the "research intermediary. Reiser SJ; Knudson P IRB; 1993; 15(2):10-1. PubMed ID: 11651567 [No Abstract] [Full Text] [Related]
17. Informed consent process is deemed "legally and ethically invalid" by witness. Maloney DM Hum Res Rep; 1995 Jan; 10(1):4-5. PubMed ID: 11660008 [No Abstract] [Full Text] [Related]
18. Issues related to the protection of human research participants. Harrison L J Neurosurg Nurs; 1993 Jun; 25(3):187-93. PubMed ID: 11660053 [No Abstract] [Full Text] [Related]
19. When the subjects are hospital staff, is it ethical (or possible) to get informed consent? Geller JL; Lidz CW; Pattulo EL IRB; 1987; 9(5):4-8. PubMed ID: 11649898 [No Abstract] [Full Text] [Related]
20. Bill of rights for research subjects. Prentice ED; Reitemeier PJ; Antonson DL; Kelso TK; Jameton A IRB; 1993; 15(2):7-9. PubMed ID: 11651568 [No Abstract] [Full Text] [Related] [Next] [New Search]